SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-002890
Filing Date
2022-01-21
Accepted
2022-01-21 16:30:14
Documents
1
Period of Report
2022-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8948
  Complete submission text file 0000899243-22-002890.txt   11240
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
PureTech Health LLC (Reporting) CIK: 0001727395 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39362 | Film No.: 22546269

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02210
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02210 617-482-2333
PureTech Health plc (Reporting) CIK: 0001782999 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39362 | Film No.: 22546270
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Issuer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations